SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants


Por: Martinez-Flores, Daniel, Zepeda-Cervantes, Jesus, Cruz-Resendiz, Adolfo, Aguirre-Sampieri, Sergio, SAMPIERI, ALICIA, Vaca, Luis

Publicada: 12 jul 2021
Resumen:
Coronavirus 19 Disease (COVID-19) originating in the province of Wuhan, China in 2019, is caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), whose infection in humans causes mild or severe clinical manifestations that mainly affect the respiratory system. So far, the COVID-19 has caused more than 2 million deaths worldwide. SARS-CoV-2 contains the Spike (S) glycoprotein on its surface, which is the main target for current vaccine development because antibodies directed against this protein can neutralize the infection. Companies and academic institutions have developed vaccines based on the S glycoprotein, as well as its antigenic domains and epitopes, which have been proven effective in generating neutralizing antibodies. However, the emergence of new SARS-CoV-2 variants could affect the effectiveness of vaccines. Here, we review the different types of vaccines designed and developed against SARS-CoV-2, placing emphasis on whether they are based on the complete S glycoprotein, its antigenic domains such as the receptor-binding domain (RBD) or short epitopes within the S glycoprotein. We also review and discuss the possible effectiveness of these vaccines against emerging SARS-CoV-2 variants.

Filiaciones:
Martinez-Flores, Daniel:
 Vaca, L (Corresponding Author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City, DF, Mexico. Martinez-Flores, Daniel

Zepeda-Cervantes, Jesus:
 Vaca, L (Corresponding Author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City, DF, Mexico. Martinez-Flores, Daniel

Cruz-Resendiz, Adolfo:
 Vaca, L (Corresponding Author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City, DF, Mexico. Martinez-Flores, Daniel

Aguirre-Sampieri, Sergio:
 Vaca, L (Corresponding Author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City, DF, Mexico. Martinez-Flores, Daniel

SAMPIERI, ALICIA:
 Vaca, L (Corresponding Author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City, DF, Mexico. Martinez-Flores, Daniel

Vaca, Luis:
 Vaca, L (Corresponding Author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City, DF, Mexico. Martinez-Flores, Daniel
ISSN: 16643224





FRONTIERS IN IMMUNOLOGY
Editorial
Frontiers Research Foundation, PO BOX 110, LAUSANNE, 1015, SWITZERLAND, Suiza
Tipo de documento: Review
Volumen: 12 Número:
Páginas:
WOS Id: 000679073300001
ID de PubMed: 34322129
imagen Open Access